Back
 OJPed  Vol.5 No.1 , March 2015
Herpes Zoster in Childhood
Abstract: Herpes zoster is caused by reactivation of latent varicella-zoster virus that resides in a dorsal root ganglion. Herpes zoster can develop at any time after a primary infection or varicella vaccination. The incidence among children is approximately 110 per 100,000 person-years. Clinically, herpes zoster is characterized by a painful, unilateral vesicular eruption in a restricted dermatomal distribution. In young children, herpes zoster has a predilection for areas supplied by the cervical and sacral dermatomes. Herpes zoster tends to be milder in children than that in adults. Also, vaccine-associated herpes zoster is milder than herpes zoster after wild-type varicella. The diagnosis of herpes zoster is mainly made clinically, based on a distinct clinical appearance. The most common complications are secondary bacterial infection, depigmentation, and scarring. Chickenpox may develop in susceptible individuals exposed to herpes zoster. Oral acyclovir should be considered for uncomplicated herpes zoster in immunocompetent children. Intravenous acyclovir is the treatment of choice for immunocompromised children who are at risk for disseminated disease. The medication should be administered ideally within 72 hours of rash onset.
Cite this paper: Leung, A. , Barankin, B. (2015) Herpes Zoster in Childhood. Open Journal of Pediatrics, 5, 39-44. doi: 10.4236/ojped.2015.51008.
References

[1]   Leung, A.K., Robson, W.L. and Leong, A.G. (2006) Herpes Zoster in Childhood. Journal of Pediatric Health Care, 20, 300-303.
http://dx.doi.org/10.1016/j.pedhc.2006.01.004

[2]   American Academy of Pediatrics (2012) Varicella Zoster Infections. In: Pickering, L.K., Baker, C.J., Kimberlin, D.W. and Long S.S., Eds., Red Book: 2012 Report of the Committee on Infectious Diseases, 29th Edition, American Academy of Pediatrics, Elk Grove Village, 774-789.

[3]   Leung, A.K. (2011) Herpes Zoster. In: Leung, A.K., Ed., Common Problems in Ambulatory Pediatrics: Specific Clinical Problems, Vol. 1, Nova Science Publishers, Inc., New York, 285-289.

[4]   Kawai, K., Gebremeskel, B.G. and Acosta, C. (2014) Systematic Review of Incidence and Complications of Herpes Zoster: Towards a Global Perspective. BMJ Open, 4, e004833.
http://dx.doi.org/10.1136/bmjopen-2014-004833

[5]   LaRussa, P.S. and Marin, M. (2011) Varicella-Zoster Virus Infection. In: Kliegman, R.M., Stanton, B.F., St Geme, J.W., Schor, N.F., Behrman, R.E., Nelson Textbook of Pediatrics, 19th Edition, Elsevier, Philadelphia, 1104-1110.
http://dx.doi.org/10.1016/B978-1-4377-0755-7.00245-1

[6]   Stein, M., Cohen, R., Bromberg, M., et al. (2012) Herpes Zoster in a Partially Vaccinated Pediatric Population in Central Isreal. Pediatric Infectious Disease Journal, 31, 906-909.
http://dx.doi.org/10.1097/INF.0b013e31825d33f9

[7]   Insinga, R.P., Itzler, R.F., Pellissier, J.M., et al. (2005) The Incidence of Herpes Zoster in a United States Administrative Database. Journal of General Internal Medicine, 20, 748-753.
http://dx.doi.org/10.1111/j.1525-1497.2005.0150.x

[8]   Schmader, K., George, L.K., Burchett, B.M., et al. (1995) Racial Differences in the Occurrence of Herpes Zoster. Journal of Infectious Diseases, 171, 701-704.
http://dx.doi.org/10.1093/infdis/171.3.701

[9]   O’Connor, K.M. and Paauw, D.S. (2013) Herpes Zoster. Medical Clinics of North America, 97, 503-522.
http://dx.doi.org/10.1016/j.mcna.2013.02.002

[10]   Staikov, I., Neykov, N., Marinovic, B., et al. (2014) Herpes Zoster as a Systemic Disease. Clinics in Dermatology, 32, 424-429.
http://dx.doi.org/10.1016/j.clindermatol.2013.11.010

[11]   Enders, G., Bolley, I., Miller, E., Cradock-Watson, J. and Ridehalgh, M. (1994) Consequences of Varicella and Herpes Zoster in Pregnancy: Prospective Study of 1739 Cases. The Lancet, 343, 1548-1551.
http://dx.doi.org/10.1016/S0140-6736(94)92943-2

[12]   Chun, C., Weinman, S., Riedlinger, K., Mullooly, J.P., Houston, H., Schmid, D.S. and Seward, J.F. (2011) Laboratory Characteristics of Suspected Herpes Zoster in Vaccinated Children. The Pediatric Infectious Disease Journal, 30, 719-721.
http://dx.doi.org/10.1097/INF.0b013e3182137e35

[13]   Tseng, H.F., Smith, N., Marcy, S.M., Sy, L.S. and Jacobsen, S.J. (2009) Incidence of Herpes Zoster among Children Vaccinated with Varicella Vaccine in a Prepaid Health Care Plan in the United States, 2002-2008. The Pediatric Infectious Disease Journal, 28, 1069-1072.
http://dx.doi.org/10.1097/INF.0b013e3181acf84f

[14]   Uebe, B., Sauerbrei, A., Burdach, S. and Horneff, G. (2002) Herpes Zoster by Reactivated Vaccine Varicella Zoster Virus in a Healthy Child. European Journal of Pediatrics, 161, 442-444.
http://dx.doi.org/10.1007/s00431-002-0981-1

[15]   Weinmann, S., Chun, C., Schmid, D.S., Roberts, M., Vandermeer, M., Riedlinger, K., et al. (2013) Incidence and Clinical Characteristics of Herpes Zoster among Children in the Varicella Vaccine Era, 2005-2009. Journal of Infectious Diseases, 208, 1859-1868.
http://dx.doi.org/10.1093/infdis/jit405

[16]   Civen, R., Chaves, S.S., Jumaan, A., Wu, H., Mascola, L., Gargiullo, P. and Seward, J.F. (2009) The Incidence and Clinical Characteristics of Herpes Zoster among Children and Adolescents after Implementation of Varicella Vaccination. The Pediatric Infectious Disease Journal, 28, 954-959.
http://dx.doi.org/10.1097/INF.0b013e3181a90b16

[17]   Rentier, B. and Gershon, A.A., The Members of the European Working Group on Varicella (Euro Var) (2004) Consensus: Varicella Vaccination of Healthy Children: A Challenge for Europe. The Pediatric Infectious Disease Journal, 23, 379-389.
http://dx.doi.org/10.1097/01.inf.0000122606.88429.8f

[18]   Kim, B.S., Mehra, S., Yawn, B., Grose, C., Tarrell, R., Lahr, B. and Juhn, Y.J. (2013) Increased Risk of Herpes Zoster in Children with Asthma: A Population-Based Case-Control Study. Journal of Pediatrics, 163, 816-821.

[19]   Quinlivan, M.L., Gershon, A.A., Steinberg, S.P. and Breuer, J. (2004) Rashes Occurring after Immunization with a Mixture of Viruses in the Oka Vaccine Are Derived from Single Clones of Virus. The Journal of Infectious Diseases, 190, 793-796.
http://dx.doi.org/10.1086/423210

[20]   Albrecht, M.A. (2014) Clinical Manifestations of Varicella-Zoster Virus Infection: Herpes Zoster. In: Post, T.W., Ed., UpToDate, UpToDate, Inc., Waltham, MA.

[21]   Leung, A.K. and Rafaat, M. (2003) Herpes Zoster. American Family Physician, 67, 1045-1046.

[22]   Zaal, M.J., Volker-Dieben, H.J. and D’Amaro, J. (2003) Prognostic Value of Hutchinson’s Sign in Acute Herpes Zoster Opthalmicus. Graefe’s Archive for Clinical and Experimental Ophthalmology, 241, 187-191.
http://dx.doi.org/10.1007/s00417-002-0609-1

[23]   De Freitas, D., Martins, E.N., Adan, C., Alvarenga, L.S. and Pavan-Langston, D. (2006) Herpes Zoster Ophthalmicus in Otherwise Healthy Children. American Journal of Ophthalmology, 142, 393-399.
http://dx.doi.org/10.1016/j.ajo.2006.03.059

[24]   Ong, O.L., Churchyard, A.C. and New, P.W. (2010) The Importance of Early Diagnosis of Herpes Zoster Myelitis. Medical Journal of Australia, 193, 546-547.

[25]   Ruppert, L.M., Freeland, M.L. and Stubblefield, M.D. (2010) Segmental Zoster Paresis of the Left Upper Limb in a Pediatric Patient. American Journal of Physical Medicine Rehabilitation, 89, 1024-1029.
http://dx.doi.org/10.1097/PHM.0b013e3181e7204b

[26]   Leung, A.K. and Barankin, B. (2015) Bilateral Symmetrical Herpes Zoster in an Immunocompetent 15-Year-Old Boy. Case Reports in Pediatrics, 2015, Article ID: 121549.

[27]   Leung, A.K., Kellner, J.D. and Davies, H.D. (2009) Chickenpox: An Update. The Pediatric Infectious Disease Journal, 4, 343-350.

[28]   Marin, M., Güris, D., Chaves, S.S., Schmid, S. and Seward, J.F., Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC) (2007) Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). The MMWR Recommendations and Reports, 56, 1-40.

 
 
Top